Allied Market Research
Upcoming Allied Market Research
Olanzapine Market

Olanzapine Market, by Therapy Type (Monotherapy and Combinational Therapy), Application (Schizophrenia, Bipolar Disorder, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), and End Users (Hospitals, Homecare, Specialty Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Jul 2022 | 107 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Olanzapine Market

Request Now !

Olanzapine, formerly known as Zyprexa, is a medicine licensed by the U.S. Food and Drug Administration (USFDA) for the treatment of schizophrenia, bipolar disorder, and other neurological disorders.

Olanzapine is a generic medication that is sold under a variety of brand names globally. Olanzapine is sold in different countries, with dosages ranging from 2.5 to 20 mg. Zyprexa (generic olanzapine) is available as an orally disintegrating "wafer" that dissolves rapidly in spit. It is also available in 10 milligrams vials for intramuscular administration. Olanzapine was first licensed for medicinal use in the U.S. in 1996. With over two million prescriptions in 2017, it was the 239th most widely prescribed drug in the U.S. Eli Lilly and Company also sells olanzapine in a fixed-dose combination with fluoxetine under the brand name olanzapine/fluoxetine.

COVID-19 Impact Analysis 

Pharmaceutical and biotech companies together with the governments are working to address the COVID-19 outbreak globally, from supporting the development of vaccines to planning for medicine supply chain challenges.

Currently, about 115 vaccine samples and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19.

Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the global olanzapine market.

Top Impacting Factors

  • The rise in the frequency of neurological disorders and the rising need for treatment of acute mania in bipolar disorders are the primary factors that drive the expansion of the olanzapine market.
  • The rise in the number of people suffering from mental illness and emotional instability boosts the need for olanzapine as a first-line treatment for such conditions.
  • As the world population grows at a rate of more than 1% per year, and individuals do not get enough neutrinos, diseases such as schizophrenia are spreading, further requiring pharmaceutical corporations to develop more medications to meet the rise in demand and benefit consumers.
  • The prevalence of emotional sickness and mental disorders is increasing as a result of the change in lifestyles and the increase in tension in job and life, which is anticipated to create lucrative growth opportunities for the olanzapine market.
  • However, medication side effects such as agitation and dysarthria and numerous regulatory requirements are expected to impede the expansion of the worldwide olanzapine market during the forecast period.

Market Trends

New Product Launches to Flourish Olanzapine Market

In June 2021, Alkermes announced that the U.S. Food and Drug Administration (USFDA) has approved LYBALVI (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. LYBALVI is a once-daily, oral atypical antipsychotic composed of olanzapine, an established antipsychotic agent, and samidorphan, a new chemical entity.

In December 2020, Novartis teamed up with Cadent Therapeutics on treatment-resistant depression back when the neuro-focused biotech was working under the radar. Swiss Pharma is helping itself to the rest of Cadent’s pipeline in a deal worth $210 million upfront but that could net the latter up to $770 million in total. Under the deal, Novartis will buy out the milestones and royalties for the depression asset, MIJ821, which it is testing in a phase 2 study. It also picks up CAD-9303, a treatment for schizophrenia, and CAD-1883, which is in development for movement disorders.

Key Benefits of Report

  • This study presents the analytical depiction of the olanzapine along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the olanzapine market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the olanzapine market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed olanzapine market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Olanzapine Market Report

  • Who are the leading market players active in the olanzapine market?
  • What current trends will influence the olanzapine market in the next few years?
  • What are the driving factors, restraints, and opportunities in the olanzapine market?
  • What future projections would help in taking further strategic steps?
  • What is olanzapine?
  • What is the olanzapine market prediction for the future?
  • Who are the leading global players in the olanzapine market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the olanzapine market report?                           

Key Market Segments

Segments Sub-segments
By Therapy Type
  • Monotherapy Therapy
  • Combinational Therapy
By Application
  • Schizophrenia
  • Bipolar Disorder
  • Other
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
By End-Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
By Region
  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • WATSON Pharmaceuticals (Changzhou Huasheng Pharmaceutical Co., Ltd.)
  • Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  • Sandoz International GmbH
  • Zhejiang Langhua Pharmaceutical Co., Ltd.
  • Aurobindo Pharma
  • Jubilant Pharmova Limited
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Dr. Reddy’s Laboratories
  • Mylan N.V.
  • Apotex Inc.
  • Teva Pharmaceutical Industries Ltd.
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Olanzapine Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers